Advertisement
The potential risk for reinfection with COVID-19 remains a concern

Risk for COVID-19 Reinfection Remains Unknown

0
Jeffrey Shaman, Ph.D., of Climate and Health Program at Columbia University, spoke with HD Live! about COVID-19 reinfection risk
A proactive monitoring program for COVID-19 can track illness

Proactive Monitoring Program Beneficial for COVID-19 Home Care

0
Total of 6,853 patients monitored as of May 21, 2020; average of nine patients/day sent to ED
After reopening

Record-High Spikes in COVID-19 Cases Seen in Arizona, Florida, Texas

0
Why numbers are rising has become a point of argument between politicians and scientists
Health insurance companies are expected to cover vaccines for the new coronavirus without charging copays

U.S. Insurers Should Not Charge Copays for COVID-19 Vaccine

0
Government has been in discussions with insurers about covering COVID-19 vaccination at no cost to patients
Most adults in New York City

Strong Support Found for Protective Practices Related to COVID-19

0
Most adults in N.Y.C., L.A., and across the U.S. support stay-at-home orders, closure of nonessential business
Implementation of more restrictive gun policies may result in a small decrease in firearm-related deaths

Drop in Firearm Deaths Linked to More Restrictive Gun Policies

0
Restrictive gun policy has 0.98 probability of being associated with decrease in firearm-related deaths
Patient-collected lower nasal specimens may be acceptable for severe acute respiratory syndrome coronavirus 2 testing

Self-Collected Nasal Swabs Acceptable for SARS-CoV-2 Testing

0
Diagnostic equivalence seen across patient-collected nasal swabs, doctor-collected nasal, oropharyngeal swabs
Mandated face coverings represent the most effective means to prevent interhuman transmission of COVID-19

Face Masks Most Effective Means to Avert COVID-19 Transmission

0
Airborne transmission is dominant route for spread; masks are determinant for shaping pandemic trend
In the treatment of COVID-19 patients

Hydroxychloroquine-Remdesivir Combo Dangerous for COVID-19 Patients

0
FDA says chloroquine or hydroxychloroquine could reduce the antiviral effectiveness of remdesivir
The cumulative incidence of COVID-19 is 403.6 cases per 100

CDC: Cumulative Incidence of COVID-19 403.6 Per 100,000 in U.S.

0
Hospitalization and mortality six times, 12 times higher for patients reporting an underlying condition